SS-31
For Research Use Only
Injectable
A mitochondria-targeting peptide (also known as elamipretide in pharmaceutical literature) that binds cardiolipin in the inner mitochondrial membrane. Research focuses on mitochondrial membrane integrity and bioenergetics in cell and disease models. Laboratory research areas include: mitochondrial membrane assays, cardiolipin binding studies, and bioenergetics research.
Size: 30mg
$250.00
In stockCheckout opens once payment is connected.
Certificates of analysis
No certificate has been published for this product yet.
Research guides
- Elamipretide (SS-31): What the Published Mitochondrial Research ReportsA research-library overview of elamipretide (SS-31), a synthetic mitochondria-targeting tetrapeptide described as binding cardiolipin in the inner mitochondrial membrane [1]. The literature summarised here is largely in vitro and animal work spanning cardiac, skeletal muscle, neural, renal, pulmonary and ocular models [3][5][6][10][15][16][17][18], alongside narrative reviews that note clinical trials have been conducted and that rigorous human data for non-approved peptide use remain limited [1][20].
- SS-31 (Elamipretide): What the Published Research ReportsA research-library overview of SS-31 (elamipretide), a mitochondria-targeted tetrapeptide, summarising what cell-based, animal, and review literature reports about its cardiolipin interaction, bioenergetic effects, and organ-specific preclinical models.
- SS-31 (Elamipretide) Animal Study Design: Models, Controls, and Endpoints in the Published LiteratureA research-framing overview of how published preclinical studies of SS-31 (elamipretide) were designed — the animal models used, comparator arms, treatment windows, and mitochondrial and functional endpoints measured — alongside the in vitro work that informs those designs.
This product is not for human or animal consumption. Misuse of this product is illegal.